CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain

Overview of attention for article published in Molecular Therapy - Methods & Clinical Development, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 6 X users

patent: 8 patents

Readers on

mendeley: 341 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Mutant reverse tetracycline transactivators for expression of genes

Grant US-12624362-B2

United States of America

12 May 2026

Cellular reprogramming to reverse aging and promote organ and tissue regeneration

Grant US-12582698-B2

United States of America

24 Mar 2026

OPTIMIZED AAV-MEDIATED TRANSDUCTION OF CARDIOMYOCYTES

Application WO-2025238182-A1

World Intellectual Property Organisation (WIPO)

20 Nov 2025

Cellular reprogramming to reverse aging and promote organ and tissue regeneration

Grant US-12414982-B2

United States of America

16 Sep 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.